What is the share price of Shalby Ltd (SHALBY) today?
The share price of SHALBY as on 20th March 2026 is ₹140.08. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Shalby Ltd (SHALBY) share?
The past returns of Shalby Ltd (SHALBY) share are- Past 1 week: -4.70%
- Past 1 month: -11.90%
- Past 3 months: -29.78%
- Past 6 months: -47.26%
- Past 1 year: -31.08%
- Past 3 years: 14.03%
- Past 5 years: 39.94%
What are the peers or stocks similar to Shalby Ltd (SHALBY)?
The peers or stocks similar to Shalby Ltd (SHALBY) include:What is the market cap of Shalby Ltd (SHALBY) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Shalby Ltd (SHALBY) is ₹1489.17 Cr as of 20th March 2026.What is the 52 week high and low of Shalby Ltd (SHALBY) share?
The 52-week high of Shalby Ltd (SHALBY) is ₹274.70 and the 52-week low is ₹137.82.What is the PE and PB ratio of Shalby Ltd (SHALBY) stock?
The P/E (price-to-earnings) ratio of Shalby Ltd (SHALBY) is 239.42. The P/B (price-to-book) ratio is 1.50.Which sector does Shalby Ltd (SHALBY) belong to?
Shalby Ltd (SHALBY) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Shalby Ltd (SHALBY) shares?
You can directly buy Shalby Ltd (SHALBY) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Shalby Ltd
SHALBY Share Price
NSE₹140.080.93% (+1.29)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
SHALBY Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
SHALBY Performance & Key Metrics
SHALBY Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 184.99 | 1.50 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 35.10 | 5.54 | 0.61% |
100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
SHALBY Company Profile
Shalby Limited operates a multi-specialty chain of hospitals. Its hospitals are tertiary care hospitals, which offer quaternary healthcare services
APOLLOHOSP
PE Ratio
72.12
72.12
1Y Return
13.75%
13.75%
Buy Reco %
86.21
86.21
MAXHEALTH
PE Ratio
86.21
86.21
1Y Return
15.06%
15.06%
Buy Reco %
81.82
81.82
FORTIS
PE Ratio
79.80
79.80
1Y Return
31.04%
31.04%
Buy Reco %
82.35
82.35
PE Ratio
42.37
42.37
1Y Return
1.99%
1.99%
Buy Reco %
80.00
80.00
ASTERDM
PE Ratio
6.12
6.12
1Y Return
44.64%
44.64%
Buy Reco %
100.00
100.00
SHALBY Sentiment Analysis
SHALBY Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
SHALBY Stock Summary · February 2026
In Q3 FY26, the company experienced a slight decline in consolidated revenue, primarily due to challenges in the hospital sector, where patient volumes dropped significantly. However, Shalby MedTech showcased remarkable growth with a 29% increase in revenue, driven by effective distribution strategies and a successful international expansion. Management remains optimistic about future profitability, focusing on operational efficiency through strategic investments in technology and infrastructure, which are expected to enhance capacity and margins. Despite facing regulatory hurdles and staffing challenges, the company is actively recruiting specialists and diversifying its service offerings, aiming for double-digit growth in the coming year. Overall, while operational challenges persist, a solid balance sheet and strategic initiatives position the company for recovery and growth.
SHALBY Stock Growth Drivers
SHALBY Stock Growth Drivers
8Strong Revenue Growth
In Q3 FY '26, Shalby Limited reported consolidated revenue of INR 949 million, reflecting a
Profitability Improvements
The company achieved a positive consolidated EBITDA of INR 29.9 million in Q3 FY '26,
SHALBY Stock Challenges
SHALBY Stock Challenges
6Revenue Decline
Shalby Limited reported a slight decrease in consolidated revenue for Q3 FY '26, down 0.6%
Decreased Profitability
The company experienced a decline in consolidated EBITDA, which fell to INR 37.5 crores with
SHALBY Forecast
SHALBY Forecasts
Price
Revenue
Earnings
SHALBY Share Price Forecast
SHALBY Share Price Forecast
2026
Current
₹140.08
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹140.08
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
SHALBY Company Revenue Forecast
SHALBY Company Revenue Forecast
2025
Current
₹1.11
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹1.11
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
SHALBY Stock EPS (Earnings Per Share) Forecast
SHALBY Stock EPS (Earnings Per Share) Forecast
2025
Current
₹0.58
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹0.58
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
SHALBY
SHALBY
Income
Balance Sheet
Cash Flow
Quarterly Normal View
SHALBY Income Statement
SHALBY Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 243.37 | 220.57 | 249.22 | 288.59 | 274.70 | 281.05 | 270.21 | 303.43 | 289.91 | 279.35 | ||||||||||
Operating & Other expenses | 185.26 | 173.72 | 205.37 | 233.68 | 234.89 | 241.73 | 244.05 | 254.89 | 243.82 | 241.87 | ||||||||||
EBITDA | 58.11 | 46.85 | 43.85 | 54.91 | 39.81 | 39.32 | 26.16 | 48.54 | 46.09 | 37.48 | ||||||||||
| Depreciation/Amortization | 12.30 | 12.40 | 15.60 | 16.37 | 16.84 | 16.32 | 16.23 | 16.52 | 17.37 | 17.61 | ||||||||||
| PBIT | 45.81 | 34.45 | 28.25 | 38.54 | 22.97 | 23.00 | 9.93 | 32.02 | 28.72 | 19.87 | ||||||||||
| Interest & Other Items | 3.17 | 3.63 | 6.47 | 8.12 | 9.26 | 10.66 | 10.67 | 9.37 | 9.65 | 10.64 | ||||||||||
| PBT | 42.64 | 30.82 | 21.78 | 30.42 | 13.71 | 12.34 | -0.74 | 22.65 | 19.07 | 9.23 | ||||||||||
| Taxes & Other Items | 15.04 | 11.74 | 5.18 | 14.76 | 10.31 | 14.16 | 10.28 | 13.73 | 10.69 | 7.46 | ||||||||||
| Net Income | 27.60 | 19.08 | 16.60 | 15.66 | 3.40 | -1.82 | -11.02 | 8.92 | 8.38 | 1.77 | ||||||||||
| EPS | 2.57 | 1.78 | 1.49 | 1.37 | 0.22 | -0.28 | -1.13 | 0.71 | 0.68 | 0.12 |
SHALBY Company Updates
FY 2026FY 2026
Investor Presentation
Feb 11PDF
Nov 13PDF
Aug 13PDF
SHALBY Stock Peers
SHALBY Past Performance & Peer Comparison
SHALBY Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Shalby Ltd | 239.42 | 1.50 | — |
| Apollo Hospitals Enterprise Ltd | 72.12 | 9.40 | 0.17% |
| Max Healthcare Institute Ltd | 86.21 | 9.89 | 0.16% |
| Fortis Healthcare Ltd | 79.80 | 6.74 | 0.12% |
SHALBY Stock Price Comparison
Compare SHALBY with any stock or ETFCompare SHALBY with any stock or ETF
SHALBY
SHALBY Holdings
SHALBY Shareholdings
SHALBY Promoter Holdings Trend
SHALBY Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
SHALBY Institutional Holdings Trend
SHALBY Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
SHALBY Shareholding Pattern
SHALBY Shareholding Pattern
SHALBY Shareholding History
SHALBY Shareholding History
Foreign Institutions
Mutual Funds Invested in SHALBY
Mutual Funds Invested in SHALBY
No mutual funds holding trends are available
Top 2 Mutual Funds holding Shalby Ltd
| Funds (Top 2) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0003% | Percentage of the fund’s portfolio invested in the stock 0.03% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 107/123 (-6) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0001% | Percentage of the fund’s portfolio invested in the stock 0.00% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 965/1037 (0) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing SHALBY stock
smallcases containing SHALBY stock
Looks like this stock is not in any smallcase yet.
SHALBY Events
SHALBY Events
SHALBY Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
SHALBY Dividend Trend
No dividend trend available
SHALBY Upcoming Dividends
SHALBY Upcoming Dividends
No upcoming dividends are available
SHALBY Past Dividends
SHALBY Past Dividends
Cash Dividend
Ex DateEx DateSep 19, 2024
Final
Final | Div/Share: ₹1.20
Dividend/Share
₹1.20
Ex DateEx Date
Sep 19, 2024
Cash Dividend
Ex DateEx DateAug 8, 2023
Final
Final | Div/Share: ₹1.20
Dividend/Share
₹1.20
Ex DateEx Date
Aug 8, 2023
Cash Dividend
Ex DateEx DateSep 19, 2022
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 19, 2022
Cash Dividend
Ex DateEx DateSep 17, 2021
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 17, 2021
Cash Dividend
Ex DateEx DateSep 4, 2020
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Sep 4, 2020
SHALBY Stock News & Opinions
SHALBY Stock News & Opinions
Articles & Videos
Earnings
Shalby reports consolidated net profit of Rs 1.77 crore in the December 2025 quarter
Net profit of Shalby reported to Rs 1.77 crore in the quarter ended December 2025 as against net loss of Rs 1.81 crore during the previous quarter ended December 2024. Sales declined 1.27% to Rs 272.13 crore in the quarter ended December 2025 as against Rs 275.63 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales272.13275.63 -1 OPM %11.1212.30 - PBDT26.8428.67 -6 PBT9.2312.35 -25 NP1.77-1.81 LP Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Shalby to hold board meeting
Shalby will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Shalby consolidated net profit rises 147.49% in the September 2025 quarter
Net profit of Shalby rose 147.49% to Rs 8.39 crore in the quarter ended September 2025 as against Rs 3.39 crore during the previous quarter ended September 2024. Sales rose 6.69% to Rs 285.43 crore in the quarter ended September 2025 as against Rs 267.54 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales285.43267.54 7 OPM %14.5812.20 - PBDT36.4430.55 19 PBT19.0713.70 39 NP8.393.39 147 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Shalby to announce Quarterly Result
Shalby will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Spotlight
Shalby slips after three-day rally
Despite today's dip, the stock has risen 43.66% in the past three months and 28.26% over six months. On a one-year basis, however, the scrip remains down 7.55%. Shalby operates 11 multispecialty tertiary hospitals and 5 orthopedic centers under the Shalby Orthopedics Center of Excellence (SOCE) across India, with a total capacity of over 2,200 beds. The company has also diversified into knee and hip implant manufacturing in the US. On a consolidated basis, net profit of Shalby declined 43.04% to Rs 8.92 crore while net sales rose 6.29% to Rs 296.43 crore in Q1 June 2025 over Q1 June 2024. Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Shalby schedules AGM
Shalby announced that the Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Shalby consolidated net profit declines 43.04% in the June 2025 quarter
Net profit of Shalby declined 43.04% to Rs 8.92 crore in the quarter ended June 2025 as against Rs 15.66 crore during the previous quarter ended June 2024. Sales rose 6.29% to Rs 296.43 crore in the quarter ended June 2025 as against Rs 278.89 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales296.43278.89 6 OPM %14.0116.21 - PBDT39.1746.79 -16 PBT22.6530.41 -26 NP8.9215.66 -43 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Shalby to convene board meeting
Shalby will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Shalby Academy to collaborate with SVVV, Indore
Shalby Academy (a unit of Shalby) has entered into a Memorandum of Understanding (MoU) with Shree Vaishnav Vidyapeeth Vishwavidyalaya (SVVV), Indore. This collaboration aims to launch undergraduate and postgraduate programs in Healthcare and Hospital Management. Under this initiative, SVVV will offer full']time BBA and MBA programs in Healthcare & Hospital Management at its Indore campus. Admissions for the first intake are set to begin shortly. Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Shalby reports consolidated net loss of Rs 11.02 crore in the March 2025 quarter
Net loss of Shalby reported to Rs 11.02 crore in the quarter ended March 2025 as against net profit of Rs 16.60 crore during the previous quarter ended March 2024. Sales rose 8.46% to Rs 264.89 crore in the quarter ended March 2025 as against Rs 244.23 crore during the previous quarter ended March 2024. For the full year,net profit declined 92.60% to Rs 6.22 crore in the year ended March 2025 as against Rs 84.08 crore during the previous year ended March 2024. Sales rose 16.41% to Rs 1086.96 crore in the year ended March 2025 as against Rs 933.75 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales264.89244.23 8 1086.96933.75 16 OPM %7.8715.92 -12.2018.96 - PBDT15.4937.38 -59 121.49180.44 -33 PBT-0.7421.78 PL 55.73128.19 -57 NP-11.0216.60 PL 6.2284.08 -93 Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 17.19%, vs industry avg of 13.4%
Over the last 5 years, market share increased from 1.21% to 1.35%
Over the last 5 years, net income has grown at a yearly rate of -25.76%, vs industry avg of 42.46%